Sir,

Interferon-associated retinopathy in a diabetic patient
Manifestations of retinal ischaemia are rarely reported complications of interferon alpha treatment.
Case report
A 59-year-old man was initially referred to the diabetic screening clinic with a 7 week history of decreasing visual acuity in both eyes and right retinal haemorrhage noticed by his optician.
Three months previously he had been found to have cerebral and pulmonary metastases from a renal cell carcinoma that had been diagnosed in 1992. At this time his full blood count, urea and electrolytes and liver function tests were normal. He was treated with oral dexamethasone, radiotherapy for the cerebral metastases and subcutaneous interferon alpha for the pulmonary metastases, and was soon found to have maturity-onset diabetes mellitus. His blood sugars were reported to be well controlled on oral gliclazide. In addition he was taking allopurinol and lansoprazole and he was an ex smoker. At this time his blood pressure was noted to be normal.
On examination in the Eye Clinic his corrected visual acuity in each eye was 6/9. Both anterior segments were normal without significant lens opacities. Fundoscopy revealed four cotton wool spots in the left eye only, without any other evidence of changes associated with diabetes. The right fundus was unremarkable, and there was no evidence of the haemorrhage previously noted by the optician. A diagnosis of diabetic retinopathy was made at this time.
The patient was reviewed 4 months later, which was 2 weeks after his interferon alpha-2A course had been stopped by the oncologists. There had been no further deterioration in his vision or any other new symptoms, although he had now developed a few cotton wool spots in both eyes ( Fig. 1) , still without any other diabetic changes. He was reviewed 2 months later, when the cotton wool spots had begun to fade (Fig. 2) .
Comment
The most commonly reported retinal changes described with interferon therapy are cotton wool spots, splinter haemorrhages, retinal haemorrhagesl. It is interesting to note that one study l found that the incidence of ischaemic retinopathic signs was increased in diabetic and hypertensive patients on interferon, suggesting a microcirculatory disturbance as the underlying pathological mechanism of retinal damage.
Interferon-associated retinopathy is a well-recognised if uncommon phenomenon, and in diabetic patients could easily be mistaken for diabetic retinopathy, as was the case with our patient initially. 
